Baycol Plaintiffs Seek Appeal Of Testimony Exclusion

Law360, New York (August 10, 2007, 12:00 AM EDT) -- The plaintiffs in the vast multidistrict litigation over cholesterol-lowering drug Baycol are lashing out at a federal judge's order granting the requests of Bayer AG and GlaxoSmithKline to exclude certain testimony of ten proposed expert witnesses presented by the plaintiffs.

In court documents filed Wednesday, the plaintiffs' steering committee asked U.S. District Judge Michael J. Davis to certify an interlocutory appeal of his July 16 order, which excluded particular testimony from all ten of the plaintiffs’ experts that Bayer and GSK had challenged. (The order, referred...
To view the full article, register now.